In tumors with elevated NSUN2 expression, simultaneous NSUN2 inhibition and ICI therapy may achieve synergistic antitumor effects: NSUN2 inhibition attenuates tumor-derived immunosuppressive signaling, while ICIs restore T cell function, resulting in dual immune activation (35). Here, NSUN2 is linked to neoplasm.